retrospectively studied 135 hospitalized COVID-19 patients and reported that there were no significant differences in ALT (P = 0.73) and total bilirubin (TBIL, P = 0.07) between mild cases (n = 95) and severe cases (n = 40) [11]. The gene discussed is GPT; the disease is COVID-19.